Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Bracco Imaging Announces Strategic Investment in PHS Technologies Group

By HospiMedica International staff writers
Posted on 05 Apr 2017
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.

Bracco’s product and solution portfolio comprises all key diagnostic imaging modalities, along with various medical devices and advanced administration systems for contrast imaging products in the fields of radiology. More...
PHS Technologies Group offers advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines, while increasing efficiency and reducing cost.

Bracco’s strategic investment in PHS Technologies Group aims at expanding its portfolio of software applications for dose management to provide healthcare organizations with the information required to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level. The agreement also strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE], a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities.

"We are pleased to reinforce our partnership with PHS Technologies," said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. "The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring."

"PHS Technologies Group is excited to expand its relationship with Bracco," said Mike Battin, Chief Operating Officer of PHS Technologies Group. "PHS is the OEM manufacturer for Bracco's NEXO[DOSE] product and will implement an expanded service and support offerings to the new markets. Furthermore, PHS will provide significant functional improvements to the application portfolio over the next 24 months."


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.